Patents by Inventor Tommaso Mecca

Tommaso Mecca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-ALKYL-D-GLUCAMINE BASED MACROPOROUS POLYMERIC CRYOGEL FOR SEQUESTERING AND/OR REMOVING TOXIC CONTAMINANTS
    Publication number: 20220259075
    Abstract: The disclosure relates to N-alkyl-D-glucamine based macroporous polymeric cryogels with three-dimensional structure and with interconnected pores, which are used for sequestering and/or removing toxic contaminants, such as toxic metalloids and/or toxic heavy metals, for example from water and/or soil and the method for the preparation of said -alkyl-D-glucamine based macroporous polymeric cryogels.
    Type: Application
    Filed: July 13, 2020
    Publication date: August 18, 2022
    Applicants: CONSIGLIO NAZIONALE DELLE RICERCHE, ALMA MATER STUDIORUM UNIVERSITA' DI BOLOGNA
    Inventors: Sabrina Carola CARROCCIO, Francesca CUNSOLO, Tommaso MECCA, Vittorio PRIVITERA, Martina USSIA, Daniele CARETTI, Stefano SCURTI
  • Cryogel for the removal of heparins and heparinoids from aqueous solutions, physiological solutions and biological fluids, preparation process and uses thereof
    Patent number: 10933384
    Abstract: The object of the present invention is a new cryopolymerization process that provides crosslinked polymeric materials in the form of a macroporous gel (cryogel) capable of sequestering (neutralize) the anticoagulant heparin, its low molecular weight derivatives (LMWH and ULMWH) and heparinoids, from aqueous solutions, physiological solutions and biological fluids, such as whole blood, serum and plasma. A further object of the invention are also crosslinked polymeric materials in the form of a macroporous gel (cryogel) obtained by the cryopolymerization process of the invention that, thanks to said specific process, result to be comprised of varying proportions of HEMA and HEMA-R monomers. The molar ratio between the components (HEMA/HEMA-R) may vary between 99.9% HEMA:0.1% HEMA-R and 0.1% HEMA:99.9% HEMA-R.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: March 2, 2021
    Assignee: Consiglio Nazionale Delle Ricerche
    Inventors: Francesca Cunsolo, Tommaso Mecca, Rita La Spina, Fabiola Spitaleri
  • Cryogel for the Removal of Heparins and Heparinoids from Aqueous Solutions, Physiological Solutions and Biological Fluids, Preparation Process and Uses Thereof
    Publication number: 20190030494
    Abstract: The object of the present invention is a new cryopolymerization process that allows to obtain crosslinked polymeric materials in the form of a macroporous gel (cryogel) capable of sequestering (neutralize) the anticoagulant heparin, its low molecular weight derivatives (LMWH and ULMWH) and heparinoids, from aqueous solutions, physiological solutions and biological fluids, such as whole blood, serum and plasma. A further object of the invention are also crosslinked polymeric materials in the form of a macroporous gel (cryogel) obtained by the cryopolymerization process of the invention that, thanks to said specific process, result to be comprised of varying proportions of HEMA and HEMA-R monomers. The molar ratio between the components (HEMA/HEMA-R) may vary between 99.9% HEMA:0.1% HEMA-R and 0.1% HEMA:99.9% HEMA-R.
    Type: Application
    Filed: February 9, 2017
    Publication date: January 31, 2019
    Inventors: Francesca Cunsolo, Tommaso Mecca, Rita La Spina, Fabiola Spitaleri
  • Abiotic heparin antagonists
    Patent number: 7465820
    Abstract: The present invention relates to heparin-binding calixarene compounds of general Formula (I) in which R, R1, L and n have the meanings indicated in the description and their use in the biomedical field.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: December 16, 2008
    Assignee: Consiglio Nazionale Delle Ricerche
    Inventors: Francesca Cunsolo, Grazia Maria Letizia Consoli, Corrada Geraci, Tommaso Mecca
  • Abiotic heparin antagonists
    Publication number: 20070082951
    Abstract: The present invention relates to heparin-binding calixarene compounds of general Formula (I) in which R, R1, L and n have the meanings indicated in the description and their use in the biomedical field.
    Type: Application
    Filed: September 16, 2004
    Publication date: April 12, 2007
    Applicant: CONSIGLIO NAZIONALE DELLE RICECHE
    Inventors: Francesca Cunsolo, Grazia Consoli, Corrada Geraci, Tommaso Mecca